Cargando…

Clinical significance of histologic subtyping of malignant pleural mesothelioma

Malignant mesothelioma (MM) is uncommon, but very aggressive tumor arising from the mesothelial cells of pleura, pericardium, peritoneum, and tunica vaginalis. Despite multimodality treatments 5-year survival is only 5% after the diagnosis. Histology and TNM staging system are still the best prognos...

Descripción completa

Detalles Bibliográficos
Autores principales:	Brcic, Luka, Kern, Izidor
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AME Publishing Company 2020
Materias:	Review Article on Selected Highlights of the 2019 Pulmonary Pathology Society Biennial Meeting
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7354152/ https://www.ncbi.nlm.nih.gov/pubmed/32676358 http://dx.doi.org/10.21037/tlcr.2020.03.38

Ejemplares similares

Integrative approach to cytologic and molecular diagnosis of malignant pleural mesothelioma
por: Hjerpe, Anders, et al.
Publicado: (2020)

Update on the pathologic diagnosis of malignant mesothelioma
por: Schulte, Jefree J., et al.
Publicado: (2020)

Controversies and challenges in the histologic subtyping of lung adenocarcinoma
por: Butnor, Kelly J.
Publicado: (2020)

Lung cancer biomarker testing: perspective from Europe
por: Thunnissen, Erik, et al.
Publicado: (2020)

Significance of tumor spread through air spaces (STAS) in lung cancer from the pathologist perspective
por: Mino-Kenudson, Mari
Publicado: (2020)

Selected highlights of the 2019 Pulmonary Pathology Society Biennial Meeting
por: Dacic, Sanja
Publicado: (2020)

Immunocytochemistry of cytology specimens for predictive biomarkers in lung cancer
por: Roy-Chowdhuri, Sinchita
Publicado: (2020)

Lung cancer biomarker tests: the history and perspective in Japan
por: Motoi, Noriko, et al.
Publicado: (2020)

Multiple faces of pulmonary large cell neuroendocrine carcinoma: update with a focus on practical approach to diagnosis
por: Baine, Marina K., et al.
Publicado: (2020)

Selected highlights of the 2019 Pulmonary Pathology Society Biennial Meeting: PD-L1 test harmonization studies
por: Lantuejoul, Sylvie, et al.
Publicado: (2020)

Histological comparison of malignant epithelioid mesothelioma in young and adult cattle
por: KAWASHIMA, Yuuto, et al.
Publicado: (2021)

Outsourcing predictive biomarker testing in non-small cell carcinoma: a personal view of pathologists
por: Brcic, Luka, et al.
Publicado: (2020)

Semirigid thoracoscopy: an effective method for diagnosing pleural malignancies
por: Rozman, Ales, et al.
Publicado: (2014)

Sequential multi-parametric MRI in assessment of the histological subtype and features in the malignant pleural mesothelioma xenografts
por: Zhang, Zhenghua, et al.
Publicado: (2023)

Interobserver Agreement in Histopathological Subtyping of Malignant Pleural Mesotheliomas
por: Mlika, Mona, et al.
Publicado: (2021)

S100A4 amplifies TGF-β-induced epithelial–mesenchymal transition in a pleural mesothelial cell line
por: Ning, Qian, et al.
Publicado: (2018)

Tumor volume is an independent predictor of survival in patients with malignant pleural mesothelioma
por: Kircheva, Diana Y, et al.
Publicado: (2015)

Diagnostic accuracy of the cancer ratio for the prediction of malignant pleural effusion: evidence from a validation study and meta-analysis
por: Zhang, Ying, et al.
Publicado: (2021)

Define the Two Molecular Subtypes of Epithelioid Malignant Pleural Mesothelioma
por: Saddozai, Umair Ali Khan, et al.
Publicado: (2022)

Two Different Serum MiRNA Signatures Correlate with the Clinical Outcome and Histological Subtype in Pleural Malignant Mesothelioma Patients
por: Lamberti, Monica, et al.
Publicado: (2015)

Clinical Significance of Soluble CD26 in Malignant Pleural Mesothelioma
por: Fujimoto, Nobukazu, et al.
Publicado: (2014)

Nonopioid analgesics discovery and the Valley of Death: EMA401 from concept to clinical trial
por: Smith, Maree T.
Publicado: (2022)

John D. Loeser Award Lecture: Size does matter, but it isn't everything: the challenge of modest treatment effects in chronic pain clinical trials
por: Smith, Shannon M., et al.
Publicado: (2020)

Primary diffuse malignant peritoneal mesothelioma in a striped skunk (Mephitis mephitis)
por: KIM, Su-Min, et al.
Publicado: (2015)

Synchronous Jejunal Sarcomatoid Carcinoma and Incidentally Associated Localized Peritoneal Malignant Mesothelioma
por: Tachibana, Mitsuhiro, et al.
Publicado: (2022)

Malignant pleural mesothelioma
por: Rao, Sukhesh
Publicado: (2009)

Clinical, Laboratory, Histological, Radiological, and Metabolic Features and Prognosis of Malignant Pleural Mesothelioma
por: Zhang, Yuan, et al.
Publicado: (2022)

Immunohistochemically detectable metallothionein expression in malignant pleural mesotheliomas is strongly associated with early failure to platin-based chemotherapy
por: Mairinger, Fabian D., et al.
Publicado: (2018)

Prognostic impact of PD-1 and PD-L1 expression in malignant pleural mesothelioma: an international multicenter study
por: Brcic, Luka, et al.
Publicado: (2021)

Comparative proteomic analysis of malignant pleural mesothelioma: Focusing on the biphasic subtype
por: Giusti, Laura, et al.
Publicado: (2016)

Learning mechanisms in pain chronification—teachings from placebo research
por: Ingvar, Martin
Publicado: (2015)

The Lancet Series call to action to reduce low value care for low back pain: an update
por: Buchbinder, Rachelle, et al.
Publicado: (2020)

Spinal cord stimulation in chronic neuropathic pain: mechanisms of action, new locations, new paradigms
por: Joosten, Elbert A., et al.
Publicado: (2020)

Peripheral pain mechanisms in osteoarthritis
por: Vincent, Tonia L.
Publicado: (2020)

William D. Willis, Jr, MD, PhD Memorial Lecture: The evolutionary history of nerve growth factor and nociception
por: Lewin, Gary R.
Publicado: (2020)

Omics approaches to discover pathophysiological pathways contributing to human pain
por: Diatchenko, Luda, et al.
Publicado: (2022)

Molecular taxonomy of nociceptors and pruriceptors
por: Kupari, Jussi, et al.
Publicado: (2023)

P14/ARF-Positive Malignant Pleural Mesothelioma: A Phenotype With Distinct Immune Microenvironment
por: Pezzuto, Federica, et al.
Publicado: (2021)

MDM2 and HIF1alpha expression levels in different histologic subtypes of malignant pleural mesothelioma: correlation with pathological and clinical data
por: Pasello, Giulia, et al.
Publicado: (2015)

Malignant pleural mesothelioma with resolution of pleural effusion
por: Nishida, Sayaka, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_k2ng20hkus70jqckv4cfpl3bej